BP002102-PRO-379: Recombinant Human Actin-like protein 6A (ACTL6A)
Source: E. Coli-derived.
Applications: ELISA; Inhibition Assays; Western Blotting.C018: Advate / Kogenate Biosimilar Stable Cell Line
The yield of Advate / Kogenate Biosimilar from the CHO stable cell line was above 60 IU/ml in a 50 liter manufacturing.
BP002108-PRO-1076: Recombinant Mycobacterium Tuberculosis major secretory protein Antigen 85A (Ag85A)
Source: Baculovirus-derived.
Purity: > 90% as determined by SDS-PAGE.BP002314-PRO-720: Recombinant Human Alpha Hemoglobin Stabilizing Protein (AHSP)
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.PA007593.m1:In Vivo Grade Recombinant Anti-human CD11a (LFA-1 alpha) Monoclonal Antibody (Clone: TS1/22.1.1.13), Mouse IgG1 Kappa
Recombinant Mouse IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade recombinant mouse monoclonal antibody (clone: TS1/22.1.1.13) specifically binds to human CD11a (LFA-1 alpha).
Applications:ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by the human CD11a (LFA-1 alpha) protein.PA007420.m1: Non-conjugated Recombinant Anti-human CD64 Monoclonal Antibody (Clone: 22), Mouse IgG1 Kappa
Recombinant mouse IgG1 Monoclonal Antibody.
Conjugation: Non-conjugated.
Specificity/Sensitivity: The recombinant 22 antibody specifically binds to human CD64.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).PA007420.h1Fs: Non-conjugated Recombinant Anti-human CD64 Monoclonal Antibody (Clone: 22), Human IgG1 Fc Silent Kappa
Recombinant human IgG1 Monoclonal Antibody with Fc silent mutation.
Conjugation: Non-conjugated.
Specificity/Sensitivity: The recombinant 22 antibody specifically binds to human CD64.
Applications: Flow cytometry (FC), and Immunohistochemistry - Frozen (IHC-F).BP003024-PRO-708: Recombinant Human Ataxin-3 (ATXN3) protein
Source: E. coli-derived.
Purity: > 90.0% by SDS-PAGE.
C019: BeneFIX Biosimilar Stable Cell Line (CHO)
The yield of BeneFIX biosimilar from the CHO stable cell line was above 20 IU/mL in a 15 liter manufacturing.
C019P: BeneFIX Biosimilar, Recombinant Factor IX
The yield of BeneFIX biosimilar from the CHO stable cell line was above 20 IU/mL in a 15 liter manufacturing.
BP001553-PRO-1063: Recombinant Human Coiled-Coil Domain Containing 101 (CCDC101) Protein
Source: E. coli-derived.
Purity: > 90% as determined by SDS-PAGE.